Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison. - Weisel, Katja; Dimopoulos, Meletios A.; Beksac, Meral; Leleu, Xavier; Richter, Joshua; Heeg, Bart; Patel, Sachin; Majer, Istvan; McFadden, Ian; Mikhael, Joseph (Leukemia & Lymphoma, 2024)